DHI
36
3
EW
55
5
MAS
46
3
PRU
39
3
MTB
38
4
UNH
42
6
AIG
38
5
AXP
63
3
PH
60
5
PYPL
49
4
KO
44
2
JNPR
59
3
EXPD
29
2
AMP
43
2
CMCSA
49
3
EQR
33
6
AON
25
4
EXPE
83
8
NKE
36
2
BAX
38
2
DHI
36
3
EW
55
5
MAS
46
3
PRU
39
3
MTB
38
4
UNH
42
6
AIG
38
5
AXP
63
3
PH
60
5
PYPL
49
4
KO
44
2
JNPR
59
3
EXPD
29
2
AMP
43
2
CMCSA
49
3
EQR
33
6
AON
25
4
EXPE
83
8
NKE
36
2
BAX
38
2
Financhill
Back

Bon Natural Life 10K Form

Sell
12

BON
Bon Natural Life

Last Price:
$1.46
Seasonality Move:
-5.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BON News And Ratings

See the #1 stock for the next 7 days that we like better than BON

BON Financial Statistics

Sales & Book Value

Annual Sales: $29.5M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $25.95
Price / Book: 0.16

Profitability

EPS (TTM): 2.10130
Net Income (TTM): $2.5M
Gross Margin: $8.8M
Return on Equity: 6.8%
Return on Assets: 5.14%

Bon Natural Life Earnings Forecast

Key Bon Natural Life Financial Ratios

  • The Gross Profit Margin over the past 6 years for BON is 29.94%.
  • The Selling, General & Administrative Expenses for BON have been equal to 8.88% of Gross Profit Margin.
  • The Research & Development expenses have been 1.01% of Revenue.
  • The Interest Expense is 5.18% of Operating Income.
  • The Net Earning history of BON is 15.57% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 4 years.

Bon Natural Life Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Chemicals
Sector: Materials
Current Symbol: BON
Website: bnlus.com

Debt

Debt-to-Equity Ratio: 0.17
Current Ratio: 2.44
Quick Ratio: 0.76

Price-to-Earnings

Trailing P/E Ratio: 0.29
Forward P/E Ratio: 0

BON Technical Analysis vs Fundamental Analysis

Sell
12
Bon Natural Life (BON) is a Sell

Is Bon Natural Life a Buy or a Sell?

  • Bon Natural Life stock is rated a Sell
    The current Bon Natural Life [BON] share price is $1.47. The Score for BON is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.